Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Hineline Lawrence J.. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Hineline Lawrence J. har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:ITCI / Intra-Cellular Therapies, Inc. | SVP of Finance, CFO | 0 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Hineline Lawrence J.. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Hineline Lawrence J. som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −64 | 0 | −100,00 | 67,12 | −4 296 | |
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 475 | 64 | −98,59 | 66,47 | −297 453 | 4 254 |
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −29 | 0 | −100,00 | 67,32 | −1 952 | |
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 100 | 29 | −97,43 | 66,54 | −73 194 | 1 930 |
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 453 | 1 129 | −79,77 | 65,28 | −290 692 | 73 701 |
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 4 539 | 4 539 | 56,73 | 257 497 | 257 497 | ||
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 582 | 5 582 | |||||
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 618 | 0 | −100,00 | 66,93 | −442 943 | |
2024-03-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 514 | 6 618 | −49,60 | 66,26 | −431 618 | 438 509 |
2024-03-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 13 132 | 13 132 | |||||
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −600 | 0 | −100,00 | 69,81 | −41 886 | |
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 282 | 600 | −89,80 | 69,47 | −366 941 | 41 682 |
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 882 | 5 882 | 36,89 | 216 987 | 216 987 | ||
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −288 | 0 | −100,00 | 70,15 | −20 203 | |
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −6 867 | 288 | −95,97 | 69,38 | −476 432 | 19 981 |
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −300 | 7 155 | −4,02 | 68,33 | −20 499 | 488 901 |
2024-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 7 455 | 7 455 | |||||
2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −185 | 0 | −100,00 | 67,35 | −12 460 | |
2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −10 998 | 185 | −98,35 | 66,61 | −732 577 | 12 323 |
2024-02-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 11 183 | 11 183 | |||||
2023-06-16 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 592 | 0 | −100,00 | 65,01 | −233 516 | |
2023-06-16 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −44 035 | 3 592 | −92,46 | 64,37 | −2 834 533 | 231 217 |
2023-06-16 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −34 227 | 47 627 | −41,81 | 63,35 | −2 168 280 | 3 017 170 |
2023-06-16 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 4 538 | 81 854 | 5,87 | 56,73 | 257 441 | 4 643 577 | |
2023-06-16 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 11 762 | 77 316 | 17,94 | 36,89 | 433 900 | 2 852 187 | |
2023-06-16 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 25 082 | 65 554 | 61,97 | 23,94 | 600 463 | 1 569 363 | |
2023-06-16 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 40 472 | 40 472 | 53,63 | 2 170 513 | 2 170 513 | ||
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −258 | 0 | −100,00 | 44,14 | −11 388 | |
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 324 | 258 | −95,38 | 44,97 | −239 420 | 11 602 |
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 582 | 5 582 | |||||
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 700 | 0 | −100,00 | 42,52 | −114 804 | |
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −12 963 | 2 700 | −82,76 | 43,17 | −559 613 | 116 559 |
2023-03-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 15 663 | 15 663 | |||||
2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −7 455 | 0 | −100,00 | 47,03 | −350 609 | |
2023-02-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 7 455 | 7 455 | |||||
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −94 | 0 | −100,00 | 49,60 | −4 662 | |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −900 | 94 | −90,54 | 48,72 | −43 848 | 4 580 |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −800 | 994 | −44,59 | 47,32 | −37 856 | 47 036 |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −8 649 | 1 794 | −82,82 | 46,54 | −402 524 | 83 493 |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 10 443 | 10 443 | |||||
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 689 | 0 | −100,00 | 50,59 | −85 447 | |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −52 279 | 1 689 | −96,87 | 49,81 | −2 604 017 | 84 129 |
2023-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 53 968 | 53 968 | 12,73 | 687 013 | 687 013 | ||
2022-09-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −33 303 | 0 | −100,00 | 45,39 | −1 511 623 | |
2022-09-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −31 861 | 33 303 | −48,89 | 45,88 | −1 461 783 | 1 527 942 |
2022-09-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 65 164 | 65 164 | 15,47 | 1 008 087 | 1 008 087 | ||
2022-03-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 16 746 | 16 746 | |||||
2022-03-14 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 13 616 | 13 616 | |||||
2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −100 | 0 | −100,00 | 50,94 | −5 094 | |
2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 983 | 100 | −97,55 | 51,64 | −205 682 | 5 164 |
2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 371 | 4 083 | −45,22 | 52,38 | −176 573 | 213 868 |
2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −7 454 | 14 910 | −33,33 | ||||
2022-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 7 454 | 7 454 | |||||
2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 627 | 0 | −100,00 | 54,99 | −254 439 | |
2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 816 | 4 627 | −55,69 | 55,72 | −324 068 | 257 816 |
2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −10 443 | 10 443 | −50,00 | ||||
2022-02-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 10 443 | 10 443 | |||||
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 100 | 0 | −100,00 | 40,07 | −164 287 | |
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −12 434 | 4 100 | −75,20 | 40,77 | −506 934 | 167 157 |
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 105 | 16 534 | −15,81 | 41,61 | −129 199 | 687 980 |
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −19 639 | 0 | −100,00 | ||||
2022-01-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 19 639 | 19 639 | |||||
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −52 880 | 10 837 | −82,99 | ||||
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −72 120 | 0 | −100,00 | ||||
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −50 000 | 0 | −100,00 | ||||
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −600 | 0 | −100,00 | 44,28 | −26 568 | |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 800 | 600 | −86,36 | 44,95 | −170 810 | 26 970 |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −9 200 | 4 400 | −67,65 | 45,81 | −421 452 | 201 564 |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −35 135 | 13 600 | −72,09 | 46,91 | −1 648 183 | 637 976 |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −100 803 | 48 735 | −67,41 | 47,84 | −4 822 416 | 2 331 482 |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −25 462 | 149 538 | −14,55 | 48,67 | −1 239 236 | 7 278 014 |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 52 880 | 175 000 | 43,30 | 15,73 | 831 802 | 2 752 750 | |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 72 120 | 122 120 | 144,24 | 17,57 | 1 267 148 | 2 145 648 | |
2021-12-23 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 50 000 | 50 000 | 16,86 | 843 000 | 843 000 | ||
2021-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 22 364 | 22 364 | |||||
2021-02-25 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 17 644 | 17 644 | |||||
2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 200 | 0 | −100,00 | 38,91 | −46 692 | |
2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −9 242 | 1 200 | −88,51 | 39,27 | −362 933 | 47 124 |
2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −10 442 | 20 886 | −33,33 | ||||
2021-02-22 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 10 442 | 10 442 | |||||
2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 376 | 0 | −100,00 | 31,64 | −75 177 | |
2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −17 262 | 2 376 | −87,90 | 32,07 | −553 592 | 76 198 |
2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −19 638 | 19 639 | −50,00 | ||||
2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 19 638 | 19 638 | |||||
2021-01-12 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
G - Gift | −350 | 0 | −100,00 | ||||
2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 100 | 350 | −89,86 | 30,94 | −95 914 | 10 829 |
2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −12 710 | 3 450 | −78,65 | 31,40 | −399 094 | 108 330 |
2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −16 160 | 0 | −100,00 | ||||
2021-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 16 160 | 16 160 | |||||
2020-11-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2020-11-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2020-11-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | −28 034 | 0 | −100,00 | 25,41 | −712 344 | ||
2020-11-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 10 000 | 28 034 | 55,45 | 3,26 | 32 600 | 91 391 | |
2020-11-13 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 10 000 | 18 034 | 124,47 | 2,84 | 28 400 | 51 217 | |
2020-09-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −26 983 | 53 968 | −33,33 | ||||
2020-09-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −41 983 | 8 034 | −83,94 | 31,14 | −1 307 351 | 250 179 |
2020-09-11 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 26 983 | 50 017 | 117,14 | 12,73 | 343 494 | 636 716 | |
2020-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 31 328 | 31 328 | |||||
2020-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 25 082 | 25 082 | |||||
2020-01-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
J - Other | −3 809 | 23 034 | −14,19 | 23,61 | −89 930 | 543 833 | |
2020-01-28 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 8 043 | 26 843 | 42,78 | ||||
2020-01-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −19 638 | 18 800 | −51,09 | 26,16 | −513 730 | 491 808 |
2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −19 638 | 39 277 | −33,33 | ||||
2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 19 638 | 38 438 | 104,46 | ||||
2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −17 591 | 18 800 | −48,34 | 30,40 | −534 766 | 571 520 |
2020-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 867 | 36 391 | −9,61 | 29,80 | −115 237 | 1 084 452 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −16 160 | 16 160 | −50,00 | ||||
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −5 298 | 0 | −100,00 | ||||
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 16 160 | 40 258 | 67,06 | ||||
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 298 | 24 098 | 28,18 | ||||
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
G - Gift | X | −1 000 | 18 800 | −5,05 | |||
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −25 | 19 800 | −0,13 | 34,30 | −858 | 679 140 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 000 | 19 825 | −4,80 | 33,28 | −33 280 | 659 776 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 982 | 20 825 | −19,30 | 32,46 | −161 716 | 675 980 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 800 | 25 807 | −6,52 | 31,84 | −57 312 | 821 695 |
2020-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 7 807 | 27 607 | 39,43 | ||||
2019-12-26 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −9 600 | 0 | −100,00 | ||||
2019-12-26 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 432 | 19 800 | −21,53 | 25,50 | −138 516 | 504 900 |
2019-12-26 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −9 600 | 25 232 | −27,56 | 25,50 | −244 800 | 643 416 |
2019-12-26 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 9 600 | 34 832 | 38,05 | 2,74 | 26 304 | 95 440 | |
2019-03-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −400 | 9 600 | −4,00 | ||||
2019-03-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −10 000 | 0 | −100,00 | ||||
2019-03-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 000 | 25 232 | −3,81 | 15,00 | −15 000 | 378 480 |
2019-03-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 400 | 26 232 | 1,55 | 2,74 | 1 096 | 71 876 | |
2019-03-01 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 10 000 | 25 832 | 63,16 | 2,74 | 27 400 | 70 780 | |
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 58 915 | 58 915 | |||||
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 80 951 | 80 951 | |||||
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
G - Gift | X | −1 200 | 15 832 | −7,05 | |||
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 108 | 17 032 | −15,43 | 12,42 | −38 601 | 211 537 |
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −3 108 | 0 | −100,00 | ||||
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 742 | 20 140 | −7,96 | 11,84 | −20 625 | 238 458 |
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −19 716 | 21 882 | −47,40 | 11,42 | −225 157 | 249 892 |
2019-01-08 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 3 108 | 41 598 | 8,07 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −16 160 | 32 320 | −33,33 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −5 298 | 5 298 | −50,00 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 16 160 | 38 490 | 72,37 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 298 | 22 330 | 31,11 | ||||
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −7 807 | 17 032 | −31,43 | 11,09 | −86 580 | 188 885 |
2019-01-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
A - Award | 7 807 | 24 839 | 45,84 | ||||
2018-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −16 319 | 17 032 | −48,93 | 20,01 | −326 543 | 340 810 |
2018-02-20 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −33 381 | 33 351 | −50,02 | 20,03 | −668 621 | 668 021 |
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 870 | 66 732 | −2,73 | 17,49 | −32 706 | 1 167 143 |
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −3 108 | 3 108 | −50,00 | ||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −3 192 | 68 602 | −4,45 | 15,67 | −50 019 | 1 074 993 |
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 3 108 | 71 794 | 4,52 | ||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 48 480 | 48 480 | |||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 65 164 | 65 164 | |||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −5 297 | 10 596 | −33,33 | ||||
2018-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 297 | 68 686 | 8,36 | ||||
2017-01-09 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −1 918 | 63 389 | −2,94 | 16,58 | −31 800 | 1 050 990 |
2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
M - Exercise | −3 107 | 6 216 | −33,33 | ||||
2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 3 107 | 65 307 | 5,00 | ||||
2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Units |
A - Award | 15 893 | 15 893 | |||||
2017-01-05 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 63 717 | 63 717 | |||||
2016-04-04 |
|
4/A | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Unit |
A - Award | 9 323 | 9 323 | |||||
2016-04-04 |
|
4/A | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 39 307 | 39 307 | |||||
2016-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Restricted Stock Unit |
A - Award | 9 323 | 9 323 | |||||
2016-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 39 307 | 39 307 | |||||
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | −10 000 | 0 | −100,00 | |||
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | −12 500 | 0 | −100,00 | |||
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | −12 500 | 0 | −100,00 | |||
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 10 000 | 62 200 | 19,16 | 1,50 | 15 000 | 93 300 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −11 264 | 52 200 | −17,75 | 52,43 | −590 572 | 2 736 846 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −11 236 | 63 464 | −15,04 | 51,50 | −578 654 | 3 268 396 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 12 500 | 74 700 | 20,10 | 1,50 | 18 750 | 112 050 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 12 500 | 62 200 | 25,15 | 1,36 | 17 000 | 84 592 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | X | −7 500 | 0 | −100,00 | |||
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −2 600 | 49 700 | −4,97 | 52,63 | −136 838 | 2 615 711 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 725 | 52 300 | −9,87 | 52,01 | −297 757 | 2 720 123 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −4 282 | 58 025 | −6,87 | 50,93 | −218 082 | 2 955 213 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −9 893 | 62 307 | −13,70 | 49,88 | −493 463 | 3 107 873 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | X | 7 500 | 72 200 | 11,59 | 0,60 | 4 500 | 43 320 |
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −5 000 | 7 500 | −40,00 | ||||
2015-12-15 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 5 000 | 64 700 | 8,38 | 0,60 | 3 000 | 38 820 | |
2015-11-27 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −5 000 | 59 700 | −7,73 | 55,00 | −275 000 | 3 283 500 |
2015-01-06 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 72 120 | 72 120 | |||||
2014-12-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −11 535 | 64 700 | −15,13 | 16,52 | −190 558 | 1 068 844 |
2014-12-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −10 965 | 76 235 | −12,57 | 16,91 | −185 418 | 1 289 134 |
2014-12-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −37 200 | 0 | −100,00 | ||||
2014-12-03 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 37 200 | 87 200 | 74,40 | 0,50 | 18 600 | 43 600 | |
2014-09-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
M - Exercise | −300 | 37 200 | −0,80 | ||||
2014-09-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
S - Sale | X | −300 | 50 000 | −0,60 | 15,00 | −4 500 | 750 000 |
2014-09-10 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Common Stock |
M - Exercise | 300 | 50 300 | 0,60 | 0,50 | 150 | 25 150 | |
2014-07-02 |
|
4 | ITCI |
Intra-Cellular Therapies, Inc.
Stock Option (right to buy) |
A - Award | 50 000 | 50 000 | |||||
2013-09-09 | 3 | NONE |
Intra-Cellular Therapies, Inc.
Common Stock |
50 000 |